FIELD: medicine.
SUBSTANCE: method involves carrying out coherent analysis electroencephalogram hemisphere interrelations to determine interhemispheric coefficients of medium coherence level belonging to bandwidth of 0-32 Hz between frontal, central, parietal, temporal and occipital brain regions. Resulting total of medium coherence level coefficients is calculated. Its reduction being greater than 20% when compared to one of healthy testees, phenylpropanolamine addiction patients remission quality is concluded to be poor.
EFFECT: high accuracy in estimating remission quality.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ESTIMATING SEVERITY OF CLINICAL COURSE OF NON-PSYCHOTIC VERSIONS OF PSYCHOORGANIC SYNDROME | 2008 |
|
RU2372841C1 |
| METHOD FOR PREDICTING OF EFFICIENCY OF TREATMENT WITH NOOCLERIN OF COGNITIVE DISORDERS IN CASE OF EPILEPSY | 2006 |
|
RU2334457C2 |
| METHOD FOR DIAGNOSING A PATHOLOGICAL DESIRE FOR ALCOHOL | 2017 |
|
RU2670910C9 |
| METHOD OF DIAGNOSTICS OF SCHIZOPHRENIC DISORDER | 2017 |
|
RU2676657C1 |
| DIAGNOSTIC TECHNIQUE FOR GENERALISED ANXIOUS DISORDER | 2009 |
|
RU2394479C1 |
| PREDICTION METHOD OF THERAPY EFFECTIVENESS IN PATIENTS WITH PAROXYSMAL SCHIZOPHRENIA | 2016 |
|
RU2621266C1 |
| METHOD OF THERAPY EFFICIENCY FORECAST IN SHIZOPHRENIA CASES BY NEUROLEPTIC MEDIA - HALOPERIDOL, OLANZAPINE, RISPERIDONE, SEROQUEL | 2008 |
|
RU2371177C1 |
| METHOD OF DIAGNOSING DISORDERS OF CEREBRAL FUNCTIONAL ACTIVITY IN PATIENTS WITH BRAIN TUMOURS | 2011 |
|
RU2473302C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PARANOID SCHIZOPHRENIA AND SCHIZO-AFFECTIVE DISORDER | 2013 |
|
RU2532309C1 |
| METHOD FOR EVALUATING THE EFFECTIVENESS OF TREATMENT OF COGNITIVE IMPAIRMENT IN PATIENTS WITH ARTERIAL HYPERTENSION | 2021 |
|
RU2777249C1 |
